Compare GSK plc (GSK) vs M&T Bank Corporation (MTB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs M&T Bank Corporation — how do they compare? GSK plc trades at $50.58 (market cap $102.60B), while M&T Bank Corporation trades at $251.93 (market cap $36.42B). The key difference: GSK plc is far larger — about 2.8× M&T Bank Corporation's market cap, and GSK plc pays the higher dividend (3.57%). Which is the better fit depends on your goals.
| GSK | MTB | |
|---|---|---|
Market Cap | $102.60B | $36.42B |
Sector | Health | Financials |
52-Week High | $61.18 | $254.04 |
52-Week Low | $38.22 | $178.63 |
Enterprise Value | $123.04B | — |
Dividend Yield | 3.57% | 2.38% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About M&T Bank Corporation
M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →
